THE EORTC STUDIES - IS THERE AN OPTIMAL ENDOCRINE MANAGEMENT FOR M1 PROSTATIC-CANCER

被引：13

作者：

ROBINSON, MRG ^{[1
]}

HETHERINGTON, J ^{[1
]}

机构：

[1] ST JAMES UNIV HOSP,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND

来源：

关键词：

D O I：

10.1007/BF00327015

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：171 / 175

页数：5

共 12 条

[1]

BENSON RC, 1983, SEMIN ONCOL, V10, P43

[2]

BRACCI U, 1977, HORMONAL THERAPY PRO

[3]

BYAR DP, 1980, BLADDER TUMORS OTHER, P471

[4]

DEVOOGT HJ, J UROL, V135, P303

[5]

Huggins C, 1941, CANCER RES, V1, P293

[6]

LABRIE F, 1985, IMPORTANT ADV ONCOLO

[7]

PANNUTI F, 1980, ROLE MEDROXYPROGESTE, P73

[8]

PAVONEMACALUSO M, 1986, J UROL

[9] Eight-year results of castration for cancer of the prostate [J].

Randall, A .

[10]

SMITH PH, 1986, J UROL